Strumento inattivo

Azioni Valeritas Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors	06/06/17
Valeritas to Host Investor Reception and Webcast on June 10 during ADA	05/06/17
Valeritas’ V-Go® Wearable Insulin Delivery Device Results in Significant Reductions in A1C, Insulin Requirements and Cost Reductions in Patients with Diabetes	22/05/17
Valeritas Reports First Quarter 2017 Financial Results	12/05/17
Valeritas to Present at the 18th Annual B. Riley Co. Investor Conference	08/05/17

Dirigenti	Titolo	Età	Da
Satish Garg PRN	Corporate Officer/Principal	-	-
Bruce W. Bode PRN	Corporate Officer/Principal	-	-

Amministratori	Titolo	Età	Da
Peter J. Devlin CHM	Chairman	56	25/04/16
Luke Düster BRD	Director/Board Member	49	01/01/16

Settore

	Variaz. 1 gen.	Capi.
SEDANA MEDICAL AB	-1,99%	209 Mln